Opposite Roles of Co-enzyme Q10 and Formaldehyde in Neurodegenerative Diseases. (24th November 2022)

• Record Type: Journal Article
• Authors: Xu, Jinan; Jin, Xingjiang; Ye, Zuting; Wang, Dandan; Zhao, Hang; Tong, Zhiqian
• Is Part Of: American journal of Alzheimer's disease & other dementias. Volume 37(2022)
• Publication Date: 2022-11-24
• Subjects: neurodegenerative diseases -- demyelination -- endogenous formaldehyde -- coenzyme Q10 -- inflammation storm; Alzheimer's disease -- Periodicals; Dementia -- Periodicals; Alzheimer's disease -- Patients -- Care -- United States -- Periodicals; 616.83
• DOI: 10.1177/15333175221143274
• Languages: English
• ISSNs: 1533-3175

Abstract

Most of neurodegenerative diseases (NDD) have no cure. The common etiology of neurodegenerations is unclear. Air pollutant-gaseous formaldehyde is notoriously known to induce demyelination and cognitive impairments. Unexpectedly, an amount of formaldehyde has been detected in the brains. Multiple factors can induce the generation and accumulation of endogenous formaldehyde. Excessive formaldehyde can induce oxidative stress to generate H2 O2 ; in turn, H2 O2 promote formaldehyde production. Clinical investigations have shown that an abnormal high level of formaldehyde but low level of coenzyme Q10 (coQ10) was observed in patients with NDD. Further studies have proven that excessive formaldehyde directly inactivates coQ10, reduces the ATP generation, enhances oxidative stress, initiates inflammation storm, induces demyelination; subsequently, it results in neurodegeneration. Although the low water solubility of coQ10 limits its clinical application, nanomicellar water-soluble coQ10 exhibits positive therapeutical effects. Hence, nanopackage of coQ10 may be a promising strategy for treating NDD.